President Donald Trump has vowed that a “major” tariff on pharmaceutical stocks is coming “very shortly,” but Bank of America ...

Citing a national security statute, the administration has begun a process to investigate the impact of imported ...

Pharmaceutical companies operate in one of the most complex regulatory and financial landscapes of any industry. They ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

In pharma, buying software (instead of building) means working with industry professionals who can develop solutions to meet ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Tánaiste Simon Harris has said it would be "inappropriate" for the United States to hit the pharmaceutical sector with ...

Medical marketers, ad agencies, physicians and pharma executives gathered for MM+M’s annual Transform conference, held at One ...

In an interview, the US pharmaceuticals giant’s international chief says Australia has made no progress in making life easier for medicine developers.

End-to-end automation could offer significant benefits: speed, accuracy, and scalability. Digital workers perform repetitive ...

Each of the drugmakers that make the fifteen medicines selected for 2027 price cuts have officially signed on to the process, giving the go-ahead for the price talks to begin. Now that the ...

Purdue Pharma filed a new bankruptcy plan on Tuesday ... votes and opt-in decisions from its creditors in May. After that process is concluded, the plan would be submitted to a U.S. bankruptcy ...